United States · Series A startup

Who invested in InterVene

3 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 27 Oct 2026

$34Mraised across 3 rounds since 2015, from 3 sources

$5.9MSeries A$15MSeries B$13MSeries A
Latest round
Series A, $13MOct 2024
Biggest round
$15MSeries B · Jun 2019
Investors
5 (1 led)
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20152017201920212023
$5.9MSeries A$15MSeries B$13MSeries A
First round
Series A, $5.9M
Mar 2015
Biggest round
$15M
Series B · Jun 2019
Usual gap between rounds
5.3 years
the median of 2

The rounds

  1. Oct 2024
    Series A$13M1 new1 returning

    Source recorded

  2. Jun 2019
    Series B$15M3 new1 returning

    Reported by FinSMEs

  3. Mar 2015
    Series A$5.9M1 new

    From a historical funding recordSEC filing: $5.9M sold, first sale Mar 2015

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Correlation VenturesVC firm2rounds
Boston ScientificVC firm2rounds
3x5 PartnersVC firm1round, led 1
LaunchCapitalVC firm1round
RiverVestVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about InterVene

Who invested in InterVene?

InterVene's investors include Correlation Ventures, Boston Scientific, 3x5 Partners, LaunchCapital and RiverVest.

How much has InterVene raised?

InterVene has raised $34M across 3 rounds since 2015.

When did InterVene last raise?

InterVene's most recent round was a Series A of $13M in Oct 2024.

What was InterVene's biggest round?

InterVene's largest round on record is $15M (Series B), in Jun 2019, led by 3x5 Partners.

Who backed InterVene first?

InterVene's first round on record, in Mar 2015, was backed by Boston Scientific.

What stage is InterVene at?

InterVene's latest named round is a Series A, in Oct 2024.

Where is InterVene based?

InterVene is based in the United States.

Who led InterVene's rounds?

3x5 Partners led the Series B in 2019.

Companies like InterVene

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.